142 related articles for article (PubMed ID: 10882007)
1. New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives.
Sonnet P; Dallemagne P; Guillon J; Enguehard C; Stiebing S; Tanguy J; Bureau R; Rault S; Auvray P; Moslemi S; Sourdaine P; Séralini GE
Bioorg Med Chem; 2000 May; 8(5):945-55. PubMed ID: 10882007
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of a new type of non steroidal human aromatase inhibitors.
Sonnet P; Guillon J; Enguehard C; Dallemagne P; Bureau R; Rault S Auvray P; Moslemi S; Sourdiane P; Galopin S; Séralini GE
Bioorg Med Chem Lett; 1998 May; 8(9):1041-4. PubMed ID: 9871704
[TBL] [Abstract][Full Text] [Related]
3. MR 20492 and MR 20494: two indolizinone derivatives that strongly inhibit human aromatase.
Auvray P; Sourdaine P; Moslemi S; Séralini GE; Sonnet P; Enguehard C; Guillon J; Dallemagne P; Bureau R; Rault S
J Steroid Biochem Mol Biol; 1999; 70(1-3):59-71. PubMed ID: 10529003
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor.
Jørgensen AS; Jacobsen P; Christiansen LB; Bury PS; Kanstrup A; Thorpe SM; Bain S; Naerum L; Wassermann K
Bioorg Med Chem Lett; 2000 Feb; 10(4):399-402. PubMed ID: 10714509
[TBL] [Abstract][Full Text] [Related]
5. Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities.
Attalah KM; Abdalla AN; Aslam A; Ahmed M; Abourehab MAS; ElSawy NA; Gouda AM
Bioorg Chem; 2020 Jan; 94():103371. PubMed ID: 31708230
[TBL] [Abstract][Full Text] [Related]
6. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
[TBL] [Abstract][Full Text] [Related]
7. New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives.
Pouget C; Fagnere C; Basly JP; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2002 Apr; 12(7):1059-61. PubMed ID: 11909717
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitors: synthesis, biological activity, and structure of 1,2-imidazolylmethylcyclopentanol derivatives.
Kato A; Ikeda Y; Sugita N; Nitta T; Enari H; Kashima A; Konno M; Niimura K
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2152-8. PubMed ID: 8582017
[TBL] [Abstract][Full Text] [Related]
9. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW
J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives.
Jørgensen AS; Jacobsen P; Christiansen LB; Bury PS; Kanstrup A; Thorpe SM; Naerum L; Wassermann K
Bioorg Med Chem Lett; 2000 Oct; 10(20):2383-6. PubMed ID: 11055361
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of a new family of steroidal aromatase inhibitors. 1. Synthesis and evaluation of a series of analogs related to 19-[(methylthio)methyl]androstenedione (RU54115).
Lesuisse D; Gourvest JF; Benslimane O; Canu F; Delaisi C; Doucet B; Hartmann C; Lefrançois JM; Tric B; Mansuy D; Philibert D; Teutsch G
J Med Chem; 1996 Feb; 39(3):757-72. PubMed ID: 8576919
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and aromatase-inhibitory activity of imidazolyl-1,3,5-triazine derivatives.
Matsuno T; Kato M; Tsuchida Y; Takahashi M; Yaguchi S; Terada S
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):291-6. PubMed ID: 9118443
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolizine/Indolizine-NSAID Hybrids: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies.
Abourehab MAS; Alqahtani AM; Almalki FA; Zaher DM; Abdalla AN; Gouda AM; Beshr EAM
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770990
[TBL] [Abstract][Full Text] [Related]
14. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.
Dumea C; Belei D; Ghinet A; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2014 Dec; 24(24):5777-5781. PubMed ID: 25453818
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
Numazawa M; Kamiyama T; Tachibana M; Oshibe M
J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
[TBL] [Abstract][Full Text] [Related]
16. 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase.
Jacobs C; Frotscher M; Dannhardt G; Hartmann RW
J Med Chem; 2000 May; 43(9):1841-51. PubMed ID: 10794700
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors.
Numazawa M; Yamaguchi S
Steroids; 1999 Mar; 64(3):187-96. PubMed ID: 10400379
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition.
Pouget C; Fagnere C; Basly JP; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2002 Oct; 12(20):2859-61. PubMed ID: 12270163
[TBL] [Abstract][Full Text] [Related]
20. Studies on aromatase inhibitors. IV. Synthesis and biological evaluation of N,N-disubstituted-5-aminopyrimidine derivatives.
Okada M; Yoden T; Kawaminami E; Shimada Y; Kudoh M; Isomura Y
Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1293-9. PubMed ID: 9301028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
